Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 28, 2025
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 28, 2025
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization.
Journal: PLoS pathogens
Published: May 10, 2025
Case Report of a Dermatologic Reaction to Wound Closure Strips and Liquid Adhesive.
Journal: Journal of education & teaching in emergency medicine
Published: March 12, 2024
The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa fever.
Journal: Communications medicine
Published: January 16, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates.
Journal: Emerging microbes & infections
Published: January 02, 2024
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models.
Journal: Human vaccines & immunotherapeutics
Published: November 27, 2023
Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo.
Journal: Frontiers in immunology
Published: October 17, 2022
Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model.
Journal: Frontiers in oncology
Published: August 12, 2022
Last Updated: 09/26/2026